A study published in this month’s issue of the journal European Neurology and published online by the U.S. National Institute of Health found that muscle stiffness multiple sclerosis marijuanaSativex – a medicinal spray made from the cannabis plant – can be an effective treatment option for “moderate to severe multiple sclerosis spasticity (MSS)”.
According to researchers: “Nabiximols (Sativex®), a cannabinoid-based oromucosal spray, is an add-on therapy for patients with moderate to severe multiple sclerosis spasticity (MSS) resistant to other medications. The primary objective was to provide real-life observational data of clinical experience of nabiximols in contrast to formal clinical trials of effectiveness.”
Researchers used an non-intervention research method with “a follow-up period of 3-4 months”; in total, 335 patients were assessed.
After conducting the study, it was concluded that; “Real-life data confirm nabiximols as an effective and well-tolerated treatment option for resistant MSS in clinical practice.”
The study was conducted by researchers at the Neurological Rehabilitation Center Quellenhof in Germany.
Another study published earlier this year by the journal Expert Review of Neurotherapeutics came to a similar conclusion, finding nabiximois to be an effective treatment for multiple sclerosis spasticity.